Drug Trial Radar · NCT07753603
Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)
Last checked: Nov 19, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
130
Planned (sponsor's estimate)
Start
Aug 4, 2026
Primary completion
Jun 30, 2028
Study completion Jun 28, 2030
Sponsor
- Lead sponsor
- Sling Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 7, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to evaluate the efficacy, safety, and tolerability of linsitinib in participants with moderate to severe Thyroid Eye Disease (TED).
Conditions
- Thyroid Eye Disease, TED
- Graves Orbitopathy
Interventions
linsitinibDrug
150 mg linsitinib is taken twice daily by mouth for 24 weeks
PlaceboDrug
0 mg placebo taken twice daily by mouth for 24 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Measure percentage of participants who are Proptosis Responders at Week 24Time frame: 24 weeks
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Sun City Clinical Research
Glendale, Arizona · Recruiting
Thrive Health Research LLC
Beverly Hills, California · Recruiting
Alliance Research Institute
Canoga Park, California · Recruiting
Pasadena Clinical Trials
Pasadena, California · Recruiting
Silkiss Eye Surgery
San Francisco, California · Recruiting
Advancing Research International, LLC
Santa Monica, California · Recruiting
Florida International Medical Research
Coral Gables, Florida · Recruiting
Rovia Clinical Research at Florida Eye Specialists
Jacksonville, Florida · Recruiting
Ophthalmic Consultants of Boston, Inc
East Weymouth, Massachusetts · Recruiting
Kahana Oculoplastic & Orbital Surgery
Livonia, Michigan · Recruiting
Advancing Research International
Las Vegas, Nevada · Recruiting
Vector Clinical Trials
Reno, Nevada · Recruiting
The Center for Eye and Facial Plastic Surgery
Somerset, New Jersey · Recruiting
Columbia University Ophthalmology
New York, New York · Not yet recruiting
Asheville Clinical Trials
Asheville, North Carolina · Recruiting
Gulf Coast Clinical Trials
Houston, Texas · Recruiting
Virginia Eye Consultants
Norfolk, Virginia · Recruiting
WVU Eye Institute
Morgantown, West Virginia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.